ANGIODROID
Angiodroid uses through a dedicated automatic injector, CO2 (a natural gas, biocompatible for humans) to drastically reduce Contrast Induced Nephropathy, a leading cause for kidney failure in patients during hospitalisation, preserving the renal function of thousands of patients, every year.
2021 SIT finalist
![Angiodroid applies a dedicated automatic injector using CO2 (a natural gas, biocompatible for humans) to drastically reduce contrast-induced nephropathy, a leading cause of kidney failure in patients during hospitalisation, preserving the renal functions of thousands of patients every year.](https://institute.eib.org/wp-content/uploads/2021/05/CO2-as-Standard-Of-Care.jpg)
Sectors: Health
Country: Italy
Country(s) of implementation: Germany, France, Italy, United Kingdom, Spain
Contact and social media
Link to WeChangers: https://wechangers.org/en/organizations/18895